Age-Related Macular Degeneration (AMD) Market Insights 2016 – Industry Overview, Competitive Playersby Pramod Kumar Digital Marketing Professional
The global age-related macular degeneration market was valued at
$5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during
2016 - 2022.
Among the various types, the wet AMD segment is expected to witness
the faster growth compared to dry AMD segment, during the forecast period. The
global age-related macular degeneration market is growing at a significant
rate, due to increasing healthcare cost, and increasing prevalence lifestyle
associated diseases, such as obesity and hypertension. In addition, the growing
geriatric population, increasing prevalence of AMD and increasing pipeline
drugs for AMD are also driving the growth of the global age-related macular
Age-related macular degeneration (AMD) is an acquired retinal disorder
indicated by fundus changes. It is one of the most common forms of visual
impairment in the geriatric population. It is a deterioration or degeneration
of macular, leading to vision loss among people aged 60 years and above. The
macula is a small part of retina responsible for sharpness and central vision.
Sample at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-market/report-sample
Smoking, obesity, high blood pressure, high cholesterol, poor diet,
ultra-violet radiation, hereditary, and light eye color are some of the risk
factors associated with AMD. In early stages, macular degeneration may not have
symptoms, although with the progress of the disease it may have symptoms such
as deterioration in central vision or dark spot, and blurriness.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=age-related-macular-degeneration-market
Geographically, North America dominated the global market of
age-related macular degeneration in 2015; whereas, the Asia-Pacific market is
expected to witness the fastest growth, during the forecast period.
Some of the key companies operating in the global age-related macular degeneration market include Novartis
AG, F. Hoffmann-La Roche Ltd., Bayer AG, Regeneron Pharmaceutical, Inc.,
Acucela, Ophthotech Corporation, Neurotech Pharmaceuticals, Inc., GlaxoSmithKline
plc, StemCells Inc and Alimera Sciences, Inc.
Created on Jun 19th 2019 22:50. Viewed 646 times.